14 trading days until the end of the quarter, management have...

14 trading days until the end of the quarter, management have said TGA approval for Orthocell-Nerve. 180 days overdue from TGAs own guidance of 236 days. Now let’s say management pull this overdue approval off, what, we might expect 5-10% increase in share price, only to be sold back down in a day or two.

Guys I’m calling for a cull, a management cull, or at the very least half pay packets until revenue increase ten fold, management are taking the piss out of us share holders, collecting huge pay packets for doing sweet FA. This type of nonsense has to be stopped, and stopped now.